Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes to Help Improve Drug Discovery
Comprehensive in vitro pro-arrhythmia assay used to validate Axol's cardiomyocytes for cardiac safety testing Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and
Source: finanznachrichten.de